Compliance Rate
Compliance Rate
50.0%
Compliant submissions
3
Incompliant submissions
3
Total trials
6
My Organizations' Clinical Trials
Showing 175 of 1457 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 10/24/19
End: 01/13/21
Due: 01/13/22
Phase: N/A
Priority: Normal
Start: 10/05/15
End: 12/21/20
Due: 12/21/21
Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 05/01/14
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/21/22
End: 04/30/24
Due: 04/30/25
Phase: N/A
Priority: Normal
Start: 06/01/19
End: 09/22/20
Due: 09/22/21
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 12/01/29
Due: 12/01/30
Phase: N/A
Priority: Normal
Start: 09/30/25
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 09/15/11
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 04/02/25
End: 04/02/28
Due: 04/02/29
Phase: N/A
Priority: Normal
Start: 05/15/25
End: 09/14/28
Due: 09/14/29
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 02/21/18
Due: 02/21/19
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 12/12/16
End: 12/16/26
Due: 12/16/27
Phase: N/A
Priority: Normal
Start: 09/16/24
End: 11/14/24
Due: 11/14/25
Phase: N/A
Priority: Normal
Start: 07/15/20
End: 11/29/23
Due: 11/29/24
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 03/01/20
Due: 03/01/21